(TORONTO, Canada – Nov. 13, 2014) – Prostate cancer researchers have developed a genetic test to identify which men are at highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy. Read the article.
Prostate cancer researchers develop personalized genetic test to predict recurrence risk Read More »
In recent years, various task forces or panels have come out strongly against using the PSA blood test as a screening tool. The latest was the Canadian Task Force on Preventive Health Care (CTFPHC) which, on Monday October 27th, 2014 stated that this test should not be used, as it does not prove to save lives!
Our Position on PSA Screening Read More »
Many men may not be getting the best advice when it comes to managing low-risk prostate cancer, two new studies suggest. In the first study, researchers found that most men are getting their prostate removed or undergoing radiation therapy when carefully watching the cancer may be just as effective without the risks and side effects of surgery or radiation. Read the article.
Doctors suggest widely varying treatments; second opinion vital Read More »
Go to the PCC website for the latest news, including New research to determine low-risk from high-risk prostate cancer and previous news items. You can also subscribe here to a monthly newsletter.
PCC News: New research to determine low-risk from high-risk prostate cancer Read More »
This site has a number of videos on early detection of metastatic prostate cancer. View them here.
Videos: Early Detection of Metastatic Prostate Cancer Read More »
January 2014 Scotiabank Awareness Night “Decision-making and patient-doctor communication regarding prostate cancer” Dr. Sharon Sharir MD, MPH, FRCSC Division of Urology, Humber River Regional Hospital Assistant Professor, Dept. of Surgery, University of Toronto CLICK ON THE ARROW TO START THE VIDEO Click here for The Complete Presentation 60:48 minutes \ The compete presentation is available in 6 parts. Click here for Presentation Part 1 Click here for Presentation Part 2 Click here for Presentation Part 3 Click here for Presentation Part 4 Click here for Presentation Part 5 Click here for Presentation Part 6 Click here for Winston Klass Thanks
Ultrasound-guided biopsies miss prostate cancers that are detected by the slightly more expensive and slightly more invasive 3D mapping biopsies. For example, in a 2006 study of 180 men diagnosed with early stage prostate cancer via ultrasound-guided biopsy, nearly a quarter were upgraded to a more clinically significant stage of disease after 3D mapping biopsy found pockets of cancer the first technique had missed. Now, a University of Colorado Cancer Center study reports the locations of these most-missed pockets of prostate cancer. Read the article.
3D Mapping Biopsy Finds 3x Prostate Cancer of Ultrasound-Guided Biopsy Read More »
Here are 2 articles on Gleason 6 Prostate Cancer: Gleason 6 Prostate Cancer: Serious Malignancy or Toothless Lion? – See More and a follow-up: Gleason 6 Cancer Is Still Cancer – See More
Gleason 6 Prostate Cancer: Serious Malignancy or Toothless Lion? Read More »
Thousands of men forced to have painful biopsies * Most are still being put through outdated tests which are not reliable * Worryingly, many get a negative result even though they have cancer * They should be given an MRI scan that can rule the disease out Read the article.
Invasive tests for prostate cancer are failing to spot the disease Read More »
Researchers from Weill Cornell Medical College have shown that the presence of a particular protein in biopsied prostate tissue substantially increases the likelihood that cancer will develop in that organ. The discovery will likely help physicians decide how closely to monitor men potentially at risk for the cancer—among the most confusing and controversial dilemmas in health care. Read the article.
Protein in prostate biopsies signals increased cancer risk Read More »